Clinical trial
Prevention of Postpartum Hemorrhage With Tranexamic Acid (TXA)
NCT03326596 is registered in ClinicalTrials.gov with United States Naval Medical Center, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Postpartum Hemorrhage With Tranexamic Acid (TXA)
- Lead sponsor
- United States Naval Medical Center, San Diego
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- April 20, 2018
- Completion date
- September 30, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.